Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.99.7 (
sialyltransferase
)
1,534
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A new fluorogenic acceptor for
sialyltransferase
, 2-[(2-pyridyl)amino]ethyl O-beta-D-galactopyranosyl-(1----4)-beta-D-glucopyranoside, was prepared from lactose as a starting material.
Sialyltransferase
activity was assayed by incubation of the enzyme with the acceptor and CMP-N-acetylneuraminic acid, separation of the fluorogenic sialylated product from the enzymatic reaction mixture by HPLC, and measurement of the product. Compared to assays so far reported that use radioactive substrates, this assay is simple and rapid. This method was used to assay
sialyltransferase
activity in human serum.
...
PMID:Simple assay for sialyltransferase activity with a new fluorogenic substrate. 322 Aug 27
Sialyltransferase
activity was measured in erythrocyte membranes and in serum in patients with myotonic dystrophy and in matched healthy controls. The reason for assaying this enzyme was to study a possible mechanism behind a previously reported deficiency of glycoprotein-bound sialic acid in the erythrocyte membrane in patients with this disease. No significant differences in
sialyltransferase
activity with endogenous or different exogenous glycoprotein acceptors were found.
...
PMID:Sialyltransferase activity in erythrocyte membranes and serum in patients with myotonic dystrophy. 322 22
A rat brain Golgi
sialyltransferase
activity capable of the differentiation-dependent control of N-CAM sialylation state is described. The specific activity of Golgi
sialyltransferase
was found to be developmentally regulated with respect to both endogenous and exogenous protein acceptors, with a particular elevation on postnatal days 10-12 when the heavily sialylated or 'embryonic' form of N-CAM is re-expressed. The subsequent developmental decrease in activity was associated with a significant decrease in apparent Km for the CMP-NeuNAc substrate, but not for the asialofetuin exogenous acceptor, which could not be attributed to the temporal expression of an endogenous competitive inhibitor. The apparent Vmax remained constant for CMP-NeuNAc but was significantly reduced for asialofetuin.
Sialyltransferase
activity, which was optimal at pH 7.0-7.5, was also modulated by various cations. Zinc abolished enzyme function, in contrast to ferric ions which stimulated activity fourfold-sevenfold. The marked activation of the adult form of the enzyme by potassium and magnesium ions, together with the alterations in kinetic constants, suggested this activity to be distinct from that derived from postnatal day-12 tissue. The kinetics of [14C]sialic acid incorporation into immuno-precipitated N-CAM demonstrated the individual polypeptides to be sialylated, possibly by addition of polysialosyl units, in a developmental sequence. The presence of four distinct
sialyltransferase
activities was demonstrated by non-denaturing gel electrophoresis followed by solid-phase enzyme assay. These isoforms were temporally expressed during development, two being correlated with the postnatal reexpression of the 'embryonic' form of N-CAM.
...
PMID:Developmental control of N-CAM sialylation state by Golgi sialyltransferase isoforms. 325 55
The acute phase protein response following inflammation is associated with an increased total protein-bound carbohydrate content in plasma in the form of glycoproteins. Glycosyltransferases in liver may serve as a regulator of this increased glycosylation activity in the plasma and may also serve as a marker for the acute phase response.
Sialyltransferase
is an example of a glycosyltransferases in which sialic acid is transferred to oligosaccharides of glycopeptides in the Golgi prior to glycopeptide secretion. In this study,
sialyltransferase
activities were determined in plasma, liver, and intestinal mucosa following a standardized 25% body surface area thermal injury in the rat. A statistically significant increase in
sialyltransferase
activity was found in liver and small intestine which were maximal at 24 hours after the injury. These increased
sialyltransferase
activities were accompanied by a statistically significant 2 to 4 fold elevation in plasma
sialyltransferase
activity at 24 hours. The plasma and liver elevations in these activities were similar to elevations seen in other models of acute inflammation using turpentine injections and bacterial infections. The increased
sialyltransferase
activity within the rat intestine was comparable to increases in intestinal
sialyltransferase
activity following colchicine treatment and may represent a similar mechanism(s).
...
PMID:Increase of sialyltransferase activity in the small intestine following thermal injury in rats. 325 79
Previous studies have demonstrated the ability of retinoic acid (RA) to inhibit the growth of two spontaneous murine melanoma cell lines (B16-F1 and S91-C2) and to augment both
sialyltransferase
activity and the sialylation of an Mr 160,000 cell-surface glycoprotein. The present study examined the effects of RA on an ultraviolet irradiation-induced murine melanoma cell line K-1735P. Like the two spontaneous melanomas, the uv-induced melanoma exhibited susceptibility to the growth-inhibitory action of RA. Both the anchorage-dependent and the anchorage-independent growths of the K-1735P cells were suppressed by RA, with IC50 values of 5 X 10(-9) and 3 X 10(-12) M, respectively.
Sialyltransferase
activity in both S91-C2 and K-1735P cells treated with 10(-6) or 10(-5) M RA increased two- and three-fold, respectively, as compared with untreated cells. In contrast, cell-surface sialo- and galactoglycoproteins, revealed by labeling with periodate and tritiated borohydrate or with neuraminidase, galactose oxidase, and tritiated borohydrate, respectively, varied between the S91-C2 and the K-1735P cells, and each cell line's modulation by RA was also distinct. These findings suggest that although RA can increase the activity of
sialyltransferase
in different melanoma cells, this increased activity may, in turn, result in an increased sialylation of distinct cell-surface glycoproteins.
...
PMID:Enhancement of sialyltransferase in two melanoma cell lines that are growth-inhibited by retinoic acid results in increased sialylation of different cell-surface glycoproteins. 339 Dec 45
The effects of phytohemagglutinin (PHA) stimulation on the activities of sialyltransferase 1 (SAT-1), and
sialyltransferase 3
(
SAT-3
), in human lymphocytes were investigated in vitro. For SAT-1 and
SAT-3
, respectively, the apparent Km values with variable CMP-NeuAc concentrations were 0.19 and 0.015 mM and with variable LacCer were 0.075 and 0.17 mM. Progressive increases in the activities of SAT-1 and
SAT-3
were detected in lymphocytes stimulated with PHA, whereas no increase was observed in control lymphocytes incubated in culture medium alone. These increased activities occurred within 18-36 h of incubation and preceded optimum lymphocyte proliferation. Intact lymphocytes were needed for the lectin-stimulated increase of
sialyltransferase
activities because neither concanavalin A nor phytohemagglutinin added to the broken cell preparation modulated SAT-1 activity. The glycolipid products formed as a result of these enzymatic reactions in the presence of endogenous and exogenous acceptors were tentatively identified by thin-layer chromatography and autofluorography. The addition of exogenous LacCer to the SAT-1 assay resulted in the radiolabeling of a small amount of ganglioside GM1b (3.4%), but GM3 was the major labeled product (96%). When GgOse4Cer was added to the
SAT-3
assay, 32% GM3 and 24.6% GM1b were detected while 44% consisted of glycolipids not labeled in assays performed without exogenous acceptors. Of the radioactivity transferred to endogenous acceptors, 81.3% was in GM3 and 14.6% in GM1b. These results demonstrate that the modulation of
sialyltransferase
activity occurs earlier than cellular activation.
...
PMID:Effects of lectin activation on sialyltransferase activities in human lymphocytes. 371 65
Sialyltransferase
activity of bovine serum with the acceptor asialofetuin exhibits a pH optimum at 6.0-6.5, no divalent cation dependence, and a Km for CMP-sialic acid of 0.05 mM. Although a 2-fold increase in
sialyltransferase
activity with the acceptor asialofetuin is observed in serum samples from 2-day-old vs 20-day-old calves, the relative activity towards other glycoprotein acceptors is not different between the groups. With the acceptor lactose, the major product (greater than 95%) for all samples is 3'-sialyllactose, suggesting that the elevated levels of
sialyltransferase
in 2-day-old calves are due to Gal-R (alpha 2-3)
sialyltransferase
.
...
PMID:Sialyltransferase of bovine serum: age- and hormone-related changes. 374 24
Serum samples of 7 cows from -10 to +10 days following parturition and of 7 calves from 0 to 20 days following birth were tested for the ability to inhibit mitogen-stimulated proliferation of lymphocytes, for cortisol and progesterone concentrations, and for sialic acid and
sialyltransferase
activity. Calf serum inhibited phytohemagglutinin (PHA)-stimulated proliferation of lymphocytes, with maximal inhibition at 12-24 h following birth, whereas no consistent immunosuppressive activity was detected in the maternal serum. Sialic acid was greatly elevated in calf serum (4.8 +/- 0.2 mumol/ml) relative to adult control values (1.3 +/- 0.1) and decreased continuously from day 0 to day 20. Sialic acid of maternal serum was slightly elevated prior to parturition (1.7 +/- 0.1) and increased to peak at 2.5 +/- 0.1 on day 8 following parturition.
Sialyltransferase
of both maternal and calf serum increased dramatically following parturition to peak at day 2. For calf serum, a moderate correlation was observed between sialic acid and cortisol concentration (r = 0.71) and between sialic acid and suppression of PHA-stimulated proliferation (r = 0.60). The results demonstrate that serum of 12-24 h-old calves is immunosuppressive in vitro, and suggest that changes in sialic metabolism may accompany cortisol-related immunosuppression in these animals.
...
PMID:Immunosuppression, sialic acid, and sialyltransferase of neonatal and maternal bovine serum. 382 Jan 92
Neisseria meningitidis serogroup B strain M986 was examined for the involvement of lipid intermediate(s) participating in the biosynthesis of the sialic acid capsular polysaccharide. The addition of exogenous undecaprenyl phosphate, phosphatidylethanolamine, or phosphatidylglycerol to particulate membranes, in the presence of cytidine 5'-monophosphosialic acid, resulted in the stimulation of
sialyltransferase
activity specifically by undecaprenyl phosphate.
Sialyltransferase
activity, after delipidation of particulate membrane proteins, was specifically reconstituted by undecaprenyl phosphate. After the addition of 14C-labeled cytidine 5'-monophosphosialic acid to particulate membranes, the level of labeled lipid intermediate(s), extracted by chloroform-methanol (2:1), increased up to a maximum level between 3.75 and 5.0 min, which subsequently decreased to a lower steady-state level. Pulse-chase experiments revealed a transient, solvent-extractable, lipid-linked component. The extracted N-acetylneuraminic acid was in polymeric form. Sequential oxidation and reduction of the extracted radioactivity followed by neuraminidase treatment revealed an average degree of polymerization of four or five N-acetylneuraminic acid residues. Bacitracin-sensitive peptidoglycan was synthesized in vitro by particulate membranes. Cross-competition experiments between peptidoglycan and capsular polysaccharide synthesis by preincubation of precursors of one pathway during synthesis of the other revealed a competitive effect for a common component. This component was believed to be a common pool of undecaprenyl phosphate. A model for the production and regulation of the capsular polysaccharide is proposed.
...
PMID:Role of lipid intermediate(s) in the synthesis of serogroup B Neisseria meningitidis capsular polysaccharide. 391 90
Polyclonal rabbit antisera against soluble human milk galactosyltransferase and bovine colostrum
sialyltransferase
were used to localize by indirect immunofluorescence the respective intracellular enzymes in primary cultures from bovine fetal kidneys and established cell lines of human and bovine fibroblasts. Staining for galactosyltransferase was juxtanuclear and crescent shaped in epitheloid cells; a similar staining, occasionally perinuclear and sparsely distributed in the cytoplasm, was found in fibroblasts. In contrast, staining for
sialyltransferase
in epitheloid kidney cells derived from the same primary culture was observed predominantly in cytoplasmic vesicles that were spread over the whole cytoplasm.
Sialyltransferase
-positive vesicles had a similar distribution in fibroblasts and often appeared concentrated around an unstained Golgi area. Thus, in both cell types galactosyl- and
sialyltransferase
were localized in different subcellular compartments. Since both galactosyl- and
sialyltransferase
participate in formation of the terminal glycan NeuAc(alpha 2----6)Gal(beta 1----4)GlcNAc(Neu, neuraminic acid) present in many N-glycosidic complex types of glycans, different subcellular compartments for these enzymes support a model of functional compartmentalization of the Golgi apparatus that is compatible with an assembly-line model for glycan chain elongation and termination.
...
PMID:Localization of galactosyl- and sialyltransferase by immunofluorescence: evidence for different sites. 392 89
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>